Cohn, Z.A. and Hirsch, J.G., The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leukocytes, J. Exp. Med., 112, 983, 1960.
2.
Bainton, D.F., The origin, content, and fate of polymorphonuclear leukocyted granules, in Phagocytic Mechanisms in Health and Disease, Williams, R. C. and Fudenberg, H. H., Eds., Intercontinental Medical Books, New York, 1972, 123.
3.
Li, C.Y., Yam, L.T., and Lam, K.Y., Studies of acid phosphatase isoenzymes in human leukocytes. Demonstration of isoenzymes cell specificity, J. Histochem. Cytochem., 18, 901, 1970.
4.
DeChatelet, L.R., Cooper, M.R., and McCall, C.E., Studies of leukocyte phosphatases. III. Inhibition of leukocyte acid phosphatase by zinc, Clin. Chem., 17, 1176, 1971.
5.
DeChatelet, L.R., McCall, C.E., Cooper, M.R., and Shirley, P.S., Inhibition of leukocyted acid phosphatase by heparin, Clin. Chem., 18, 1532, 1972.
6.
Avila, J.L. and Convit, J., Characterization and properties of alpha-D-mannosidase of human polymorphonuclear leukocytes, Clin. Chim. Acta, 47, 335, 1973.
7.
Avila, J.L. and Convit, J., Heterogeneity of acid phosphatase activity in human polymorphonuclear leukocytes, Clin. Chim. Acta, 44, 21, 1973.
8.
Avila, J.L. and Convit, J., Studies on human polymorphonuclear leukocyte enzymes. I. Assay of acid hydrolases and other enzymes, Biochim. Biophys. Acta, 293(2), 397, 1987.
9.
Avila, J.L. and Convit, J., Studies on human polymorphonuclear leukocytes enzymes. IV. Intracellular distribution and properties of alpha-L-fucosidase, Biochim. Biophys. Acta, 358(2), 308, 1974.
10.
Yeh, A.K., Tulsiani, D.R., and Carubelli, R., Neuraminidase activity in human leukocytes, J. Lab. Clin. Med., 78, 771, 1971.
11.
Eschenbach, C., Cytochemischer nachweis von saurer desoxyribonuclease in cytoplasama von blutzellen. I. Methode, Histochemie, 24, 85, 1970.
12.
Davies, P., Rita, G.A., Krakaur, K., and Weissmann, G., Characterization of neutral protease from lysosomes of rabbit polymorphonuclear leukocytes, Biochem. J., 123, 559, 1971.
13.
Raindler, R., Schmalzl, F., Hortnagl, H., and Braunsteiner, H., Napthol AS-D chloracetate esterases in granule extracts from human neutrophil leukocytes, Blut, 23, 223, 1971.
14.
Riette, C. and Piette, M., Cytoenzymologic localization of an esterose active on naphol AS-D chloracetate in primary granulation of neutrophilic granulocytes in human blood, Ann. Pharm. Fr., 34(1-2), 19, 1976.
15.
Dewald, B., Rindler-Ludwig, R., Bretz, U., and Bagiolini, M., Subcellular localization and heterogeneity of neutral proteases in neutrophilic polymorphonuclear leukocytes, J. Exp. Med., 141, 709, 1975.
16.
Spitnagel, J.K., Dalldorf, F.G., Leffell, M.S., Folds, J.D., Welsh, I.R.H., Cooney, M.H., and Martin, L.E., Character of azurophil and specific granules purified from human polymorphonuclear leukocytes, Lab. Invest., 30, 774, 1974.
17.
Spitznagel, J.K., Sorting out lysosomes and other cytoplasmic granules from polymorph's of rabbits and humans: a search for antimicrobial factors, in Phagocytic Mechanism in Health and Disease, Williams, R. C. and Fudenberg, H. H., Eds., Intercontinental Medical Books, New York, 1972, 83.
18.
Baggiolini, M., Dewald, B., Rindler-Ludwig, R., and Bretz, U., Discussion paper: subcellular localization and heterogeneity of neutral proteases in human polymorphonuclear leukocytes, Ann. N.Y. Acad. Sci., 256, 263, 1975.
19.
Janoff, A. and Scherer, J., Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes, J. Exp. Med., 128, 1137, 1968.
20.
Janoff, A., Alanine p-nitrophenyl esterase activity of human leukocyte granules, Biochem. J., 114, 157, 1969.
21.
Lazarus, G.S., Brown, R.S., Daniels, J.R., and Fullmer, H.M., Human granulocyte collagenase, Science, 159, 1483, 1968.
22.
Lazarus, G.S., Daniels, J.R., Brown, R.S., Bladen, H.A., and Fullmer, H.M., Degradation of collagen by human granulocyte collagenolytic system, J. Clin. Invest., 47, 2622, 1968.
23.
Spitznagel, J.K. and Zeya, H.I., Basic proteins and leukocyte lysosomes as biochemical determinants of resistance to infection, Trans. Assoc. Am. Physicians, 77, 126, 1964.
24.
Welsh, I.R. and Spitznagel, J.K., Distribution of lysosomal enzymes, cationic proteins, and bacteriocidal substances in subcellular fractions of human polymorphonuclear leukocytes, Infect. Immun., 4, 97, 1971.
25.
Olsson, I. and Venge, P., Cationic proteins of humans granulocytes. I. Isolation of the cationic proteins of the granules of leukemic myeloid cells, Scand. J. Haemotol., 44, 204, 1972.
26.
Olsson, I. and Venge, P., Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid, Blood, 44, 235, 1974.
27.
Lehrer, R.I., Ladra, K.M., and Hake, R.B., Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes, Infect. Immun.. 11, 1226, 1975.
28.
Agner, K., Verdoperoxidase ferment isolated from leukocytes, Acta Physiol. Scand., 2(Suppl. 8), 1, 1941.
29.
Schultz, J. and Kaminker, K., Myeloperoxidase of the leukocyte from normal human blood. I. Content and localization, Arch. Biochem., 96, 465, 1962.
30.
Rohrer, G.F., Von Wartburg, J.P., and Aebi, H., Myeloperoxidase aus menschilichen leukocyten. I. Isolierng und chrakterisierung des enzymes, Biochem. Aeitschr., 344(5), 478, 1966.
31.
Mason, D.Y. and Taylor, C.R., The distribution of muramidase (lysozymes) in human tissues, J. Clin. Pathol., 28, 124, 1975.
32.
Klockars, M. and Reitamo, S., Tissue distribution of lysozyme in man, J. Histochem. Cytochem., 23, 932, 1975.
33.
Masson, P.L., Heremans, J.F., and Schonne, E., Lactoferrin, an iron-binding protein in neutrophilic leukocytes, J. Exp. Med., 130, 643, 1969.
34.
Robertson, P.B. and Fullmer, H.M., Collagenolytic activity in periodontal disease, Ala. J. Med. Sci., 10, 115, 1973.
35.
Robertson, P.B., Ryel, R.B., Fullmer, H.M. et al., Polymorphonuclear leukocyte collagenase: localization in granules subjected to zonal centrifugation, J. Oral Pathol., 1, 107, 1972.
36.
Murphy, G., Reynolds, J.J., Bretz, U., and Baggionini, M., Collagenase is a component of the specific granules of human neutrophil leukocytes, Biochem. J., 162, 195, 1977.
37.
Borregaard, N. and Tauber, A.I., Subcellular localization of human neutrophil NADPH oxidase: b-cytochrome and associated flavoprotein, J. Biol. Chem., 259, 47, 1984.
38.
Wetzl, B.K., Spicer, S.S., and Horn, R.G., Fine structural localization of acid and alkaline phosphatases in cells of rabbit blood and bone marrow, J. Histochem. Cytochem., 15, 311, 1967.
39.
Bainton, D.F. and Farquhar, M.G., Differences in enzyme content of azurophil and specific granules of polymorphonuclear leukocytes. I. Histochemical staining of bone marrow smears, Cell Biol., 29, 286, 1968.
40.
Bainton, D.F. and Farquhar, M.G., Differences in enzyme content of azurophil and specific granules of polymorphonuclear leukocytes. II. Cytochemistry and electron microscopy of bone marrow cells, J. Cell Biol., 39, 299, 1968.
41.
Baggiolini, M., Hirsch, J.G., and DeDuve, C., Resolution of granules from rabbit heterophil leukocytes into distinct propulations by zonal centrifugation, J. Cell Biol., 40, 529, 1969.
42.
Bainton, D.F., Ullyot, J.L., and Farquhar, M.G., The development of neutrophilic polymorphonuclear leukocytes in human bone marrow, J. Exp. Med., 134, 907, 1971.
43.
West, B.C., Rosenthal, A.S., Gelb, N.A., and Kimball, H.R., Separation and characterization of human neutrophil granules, Am. J. Pathol., 77, 41, 1974.
44.
Kane, S.P. and Peters, T.J., Analytical subcellular fractionation of human granulocytes with reference to the localization of vitamin B12-binding proteins, Clin. Sci. Mol. Med., 49, 171, 1975.
45.
Wright, D.G. and Gallin, J.I., Secretory responses of human neutrophils: exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo, J. Immunol., 123, 285, 1979.
46.
Borregaard, N., Heiple, J.M., Simons, E.R., and Clark, R.A., Subcellular localization of the β-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation, J. Cell Biol., 97, 52, 1983.
47.
Brentwood, B.J. and Henson, P.M., The sequential release of granule constituents from human neutrophils, J. Immunol., 124, 855, 1989.
48.
Smolen, J.E. and Weissman, G., Stimuli which provoke secretion of azurophil granules induce increments in adenosine cyclic 3',5'monophosphate, Biochim. Biophys. Acta, 672, 197, 1981.
49.
Petrequin, P.R., Todd, R.F., III, Devall, L.J. et al., Association between gelatinase release and increased plasma membrane expression of the Mol glycoprotein, Blood, 69, 605, 1987.
50.
Anderson, D.C., Schmaltieg, F.C., Arnout, M.A., et al., Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence, J. Clin. Invest., 74, 536, 1984.
51.
Wright, D.G. and Gallin, J.I., A functional differentiation of human neutrophil granules: generation of C5a by specific (secondary) granule product and inactivation of C5a by azurophil (primary) granule products, J. Immunol., 119, 1068, 1977.
52.
Broxmeyer, H.E., DeSousa, M., Smithyman, A. et al., Specificity and modulation of the action of lactoferrin, a negative feedback regulator of myelopoiesis, Blood, 55, 324, 1980.
53.
Boxer, L.A., Haak, R.A., Yang, H.H. et al., Membrane-bound lactoferrin alters the surface properties of polymorphonuclear leukocytes, J. Clin. Invest., 70, 1049, 1982.
54.
Fletcher, M.P. and Gallin, J.I., Human neutrophils contain an intracellular pool of putative receptors of chemoattractant N-formyl-methionyl-lecyl-phenylalanine, Blood, 62, 792, 1983.
55.
Todd, R.F., III, Arnout, M.A., Rosin, R.E. et al., Subcellular localization of the large subunit of Mol, a surface glycoprotein associated with neutrophil adhesion, J. Clin. Invest., 74, 1280, 1984.
56.
O'Shea, J.J., Brown, E.J., Seligmann, B.E. et al., Evidence for distinct intracellular pools of receptors for C3b and Cebi in human neutrophils, J. Immunol., 134, 2480, 1985.
57.
Yoon, P.S., Boxer, L.A., Mayo, L.A. et al., Human neutrophil laminin receptor expression, J. Immunol., 138, 259, 1987.
58.
Balazovich, K.J., Smolen, J.E., and Boxer, L.A., Endogenous inhibitor of protein kinase C: association with human peripheral blood neutrophils but not with specific granule-deficient neutrophils or cytoplasts, J. Immunol., 137, 1665, 1986.
59.
Shannon, W.A., Jr. and Zallmer, D.M., Heterogeneity in polymorphonuclear leukocyte neutrophil granules, Histochem. J., 14, 847, 1982.
60.
Bretz, U. and Baggiollini, M., Biochemical and morphological characterization of azurophil and specific granules of human neutrophilic polymorphonuclear leukocytes, J. Cell Biol., 63, 251, 1974.
61.
Segal, A.W., Dorling, J., and Coade, S., Kinetics of fusion of the cytoplasmic granules with phagocytic vacuoles in human polymorphonuclear leukocytes: biochemical and morphological studies, J. Cell Biol., 85, 42, 1980.
62.
Pember, S. 0., Shapira, R., and Kinkade, J.M., Multiple forms of myeloperoxidase from human neutrophilic granulocytes: evidence for differences in compartmentalization, enzymatic activity, and subunit structure, Arch. Biochem. Biophys., 221, 391, 1983.
63.
Kinkade, J.M., Pember, S. 0., Barnes, K.C., Shapira, R., Spitznagel, J.K., and Martin, L.E., Differential distribution of distinct forms of myeloperoxidase in different azurophilic granule subpopulations from human neutrophils, Biochem. Biophys. Res. Commun., 114, 296, 1983.
64.
Pember, S.O. et al., Blood, in press.
65.
Scott, R.E. and Horn, R.G., Ultrastructural aspects of neutrophil granulocyte development in humans, Lab. Invest., 23, 202, 1970.
66.
Brederoo, P., van der Meulen, J., and Mommaas-Keinhuis, A.M., Development of the granule population in neutrophil granulocytes from human bone marrow, Cell Tissue Res., 234, 469, 1983.
67.
Clark, J.M., Vaughan, D.W., Aiken, B.M., and Kagan, H.M., Elastase-like enzymes in human neutrophils localized by ultrastructural cytochemistry, J. Cell Biol., 84, 102, 1980.
68.
Fittschen, C., Parmley, R.T., Austin, R.L., and Crist, W.M., Vicinal glycol-staining identifies secondary granules in human normal and Chediak-Higashi neutrophils, Anat. Rec., 205, 301, 1983.
69.
Parmley, R.T., Hurst, R.E., Takagi, M., Spicer, S.S., and Austin, R.L., Glycosaminoglycans in human neutrophils and leukemic myeloblasts: ultrastructural, cytochemical, immunologic, and biochemical characterization, Blood, 257, 61, 1983.
70.
Marchesi, V.T. and Florey, H.W., Electron micrographic observation on the emigration of leukocytes, J. Exp. Physiol., 45, 343, 1960.
71.
Springer, T.A., Dustin, M.L., Kishimoto, T.K., and Marlin, S.D., The lymphocyte function-associated CFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system, Annu. Rev. Immunol., 5, 223, 1987.
72.
Anderson, D.C. and Springer, T.A., Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and pl50,95 glycoproteins, Annu. Rev. Med., 38, 175, 1987.
73.
Kishimoto, T.K., Hollander, N., Roberts, T.M., Anderson, D.C., and Springer, T.A., Heterogeneous mutation in the β subunit common to the LFA-1, Mac-1, and pl50,95 glycoproteins cause leukocyte adhesion deficiency, Cell, 50, 193, 1987.
74.
Hynes, R. 0., Integrins: a family of cell surface receptors, Cell, 48, 549, 1987.
75.
Ruoslahti, E. and Pierschbacher, M.D., New perspectives in cell adhesion: RGD and integrins, Science, 238, 491, 1987.
76.
Kishimoto, T. K., Miller, L. J., and Springer, T. A., Leukocyte Typing III, McMichael, A., Ed., Springer-Verlag, New York, 1987, 896.
77.
Sanchez-Madrid, R., Nagy, J., Robbins, E., Simon, P., and Springer, T.A., A human leukocyte differentiation antigen family with distinct alpha subunits and a common beta subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM-1, Mac-1), and the pl50,95, molecule, J. Exp. Med., 158, 1785, 1983.
78.
Harris, H., Role of chemotaxis in inflammation, Physiol. Rev., 34, 529, 1954.
79.
Ward, P.A., Lepow, I.H., and Newman, L.J., Bacterial factors chemotactic for polymorphonuclear leukocytes, Am. J. Pathol., 52, 725, 1968.
80.
Ruddy, S., Chemistry and biologic activity of the complement system, Transplant Proc., 6, 1, 1974.
81.
Muller-Eberhard, H.J., Complement and phagocytosis, in The Phagocytic Cell in Host Resistance, Bellonti, J. A. and Dayton, D. H., Eds., Raven Press, New York, 1975, 87.
82.
Frank, M.M. and Atkinson, J.P., Complement in clinical medicine, Disease-a-Month, January, 1, 1975.
83.
Stecher, V.J., Sorkin, E., and Ryan, G.B., Relation between blood coagulation and chemotaxis of leukocytes, Nature (London), 233, 95, 1971.
84.
Kaplan, A.P., Goetzl, E.J., and Austen, K.F., The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator, J. Clin. Invest., 52, 2591, 1973.
85.
Weksler, B.B. and Coupal, C.E., Platelet-dependent generation of chemotactic activity in serum, J. Exp. Med., 137, 1419, 1973.
86.
Cornely, H.P., Reversal of chemotaxis in vitro and chemotactic activity of leukocyte fractions, Proc. Soc. Exp. Biol. Med., 112, 983, 1960.
87.
Zigmond, S.H. and Hirsch, J.G., Leukocyte locomotion and chemotaxis. New methods for evaluation and demonstration of cell-derived chemotactic factor, J. Exp. Med., 137, 387, 1973.
88.
Tynelius-Bratthall, G. and Lindhe, J., Neutrophil chemotactic activity of rabbit neutrophils, Arch. Oral Biol., 19, 97, 1974.
89.
Wright, D.G. and Gallin, J.I., Modulation of the inflammatory response by products released from human polymorphonuclear leukocytes during phagocytosis. Generation and inactivation of the chemotactic factor C5a, Inflammation, 1, 23, 1975.
90.
Altman, L.C., Snyderman, R., Oppenheim, J.J., and Mergenhagen, S.E., A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes, J. Immunol., 110, 801, 1973.
91.
Altman, L.C., Chassy, B., and Mackler, B.F., Physicochemical characterization of chemotactic lymphokines produced by human T and B lymphocytes, J. Immunol., 115, 18, 1975.
92.
Rosenberg, G.L., Snyderman, R., and Notkins, A.L., Production of chemotactic factor and lymphotoxin by human leukocytes stimulated with Herpes simplex virus, Infect. Immun., 10, 111, 1974.
93.
Snyderman, R. and Goetzl, E.J., Molecular and cellular mechanisms of leukocyte chemotaxis, Science, 213, 830, 1981.
94.
Chang, C. and Houck, J.C., Demonstration of the chemotactic properties of collagen, Proc. Soc. Exp. Biol. Med., 134, 22, 1970.
95.
Grimes, G.J. and Barnes, F.S., A technique for studying chemotaxis of leukocytes in well-defined chemotactic fields, Exp. Cell Res., 79, 375, 1973.
96.
Rabson, A.R., Anderson, R., and Glover, A., Defective neutrophil motility and recurrent infection. In vitro and in vivo effect of Levamisole®, Clin. Exp. Immunol., 33, 142, 1978.
97.
Keller, H.U. and Sorkin, E., Studies on chemotaxis. VI. Specific chemotaxis of rabbit polymorphonuclear cells, Int. Arch. Allergy Appl. Immunol., 31, 575, 1967.
98.
Wilkinson, P.C., Characterization of chemotactic activity of casein for neutrophil leukocytes and macrophages, Experientia, 28, 1051, 1972.
99.
Aoki, T. Shimizu, A., and Yamamura, Y., Leukocyte chemotactic factor generated by tryptic digestion of human IgM, Immunology, 117, 428, 1976.
100.
Wilkinson, P.C., Succinyl bee venom melittin is a leukocyte chemotactic factor, Nature (London), 267, 713, 1977.
101.
Schiffman, E., Corcoran, B.A., and Wahl, S.M., N-Formylmethionyl peptides as chemoattracts for leukocytes, Proc. Natl. Acad. Sci. U.S.A., 72, 1059, 1975.
102.
Schiffman, H.J., Freer, R.J., Zigmond, S.H., and Becker, E.L., The structure activity relations of synthetic peptides as chemotactic factors, and inducers of lysosomal secretion for neutrophils, J. Exp. Med., 143, 1154, 1976.
103.
Schiffman, E., Molecular events in leukocyte chemotaxis: their possible roles in processing the chemical signal, Biosci. Rep., 1, 89, 1981.
104.
Zigmond, S.H., The ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factor, J. Cell Biol., 75, 606, 1977.
105.
Williams, L.T., Snyderman, R., Pike, M.C., and Lefkowitz, R.J., Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocyte, Proc. Natl. Acad. Sci. U.S.A., 74, 1204, 1977.
106.
Niedel, J.E., Kahane, I., and Cuatrecasas, P., Receptor-mediated internalization of fluorescent chemotactic peptide by human neutrophils, Science, 205, 1412, 1979.
107.
Chenoweth, D.E. and Hugli, T.E., Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes, Proc. Natl. Acad. Sci. U.S.A., 75, 3943, 1978.
108.
Stadel, J.M., DeLean, A., and Lefkowitz, R.J., Molecular mechanisms of coupling in hormone receptor-adenylate cyclase systems, Adv. Enzymol., 53, 1, 1982.
109.
Lad, P.M., Welton, A.F., and Rodbell, M., Evidence for distinct guanine nucleotide sites in the regulation of the gluragon receptor and of adenylate cyclase activity, J. Biol. Chem., 252, 5942, 1977.
110.
Burgisser, G., DeLean, A., and Lefkowitz, R.J., Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide, Proc. Natl. Acad. Sci. U.S.A., 79, 1732, 1982.
111.
DeLean, A., Kilpatrick, B.F., and Caron, M.G., Dopamine receptor of the porcine anterior pituitary gland: evidence for two affinity states discriminated by both agonists and antagonists, Mol. Pharmacol., 22, 290, 1980.
112.
Verghese, M.W., Smith, C.D., and Snyderman, R., Role of guanine nucleotide regulatory protein in polyphosphoinositide degradation and activation of phagocytic leukocytes by chemoattractants, J. Cell Biochem., 32, 59, 1986.
113.
Snyderman, R., Pike, M.C., Edge, S., and Lane, B.C., A chemoattractant receptor on macrophages exist in two affinity states regulated by guanine nucleotides, J. Cell Biol., 98, 444, 1984.
114.
Smith, C.W., Hollers, J.C., Patrick, R.A., and Hassett, C., Motility and adhesiveness in human neutrophil, J. Clin. Invest., 63, 221, 1979.
115.
Cianciolo, G.J. and Snyderman, R., Monocyte responsiveness to chemotactic stimuli is a property of a subpopulation of cells that can respond to multiple chemoattractants, J. Clin. Invest., 67, 60, 1981.
116.
Omann, G.M., Allen, R.A., Bokoch, G.M. et al., Signal transduction and cytoskeletal activation in the neutrophil, Physiol. Rev., 67, 285, 1987.
117.
Goldstein, I., Hoffstein, S., Gallin, J., and Weisman, G., Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement, Proc. Natl. Acad. Sci. U.S.A., 70, 2916, 1973.
118.
Klebanoff, S.J. and Clark, R.A., The Neutrophil: Function and Clinical Disorders, North-Holland, New York, 1978, 172.
119.
Yuli, I., Tomonage, and Snyderman, R., Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers, Proc. Natl. Acad. Sci. U.S.A., 79, 5906, 1982.
120.
Lohr, K.M. and Snyderman, R., Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes, J. Immunol., 129, 1594, 1982.
121.
Berridge, M.J. and Irvine, R.F., Inositol triphosphate: a novel second messenger in cellular signal transduction, Nature (London), 312, 315, 1984.
122.
Cockcroft, S., The dependence on Ca2- of the guanine-nucleotide activated polyphosphoinositide phosphodieterase in neutrophil plasma membranes, Biochem. J., 240, 503, 1986.
123.
Snyderman, R. and Goetzl, E.F., Molecular and cellular mechanisms of leukocyte chemotaxis, Science, 213, 830, 1981.
124.
Naccache, P.A., Sha'afi, R.I., Borgeat, P. et al., Mono- and dehydroxyeicosatetraenoic acids alter calcium homeostasis in rabbit neutrophils, J. Clin. Invest., 67, 1584, 1981.
125.
Goldman, D.W., Gifford, L.A., Olson, D.M., et al., Transduction by leukotriene B4 receptors of increases in cytosolic calcium in human polymorphonuclear leukocytes, J. Immunol., 135, 525, 1985.
126.
Ward, P.A., Salavik, M.C., and Hohnson, K.J., Activated neutrophils: correlation of arachidonate products with enzyme secretion but not O2-generation, Am. J. Pathol., 120, 112, 1985.
127.
Stenson, W.F. and Parker, C.W., Metabolism of arachidonic acid in ionophore-stimulated neutrophils: esterification of a hydroxylated metabolite into phospholipids, J. Clin. Invest., 64, 1457, 1979.
128.
Malech, H.L., Root, R.K., and Gallin, J.I., Structural analysis of human neutrophil migration. Centriole, microtubule, and microfilament orientation and function during chemotaxis, J. Cell Biol., 75, 666, 1977.
129.
Walter, R.J., Barkin, R.D., and Oliver, J.M., Asymmetric Fc receptor distribution on human PMN oriented in a chemotactic gradient, Nature (London), 268, 724, 1980.
130.
Gallin, J.I., Wright, D.G., and Schiffman, E., Role of secretory events in modulating human neutrophil chemotaxis, J. Clin. Invest., 62, 1364, 1978.
131.
Fletcher, M.P., Seligmann, B.E., and Gallin, J.I., Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity, J. Immunol., 128, 941, 1982.
132.
Griffin, F.M., Jr., Griffin, J.A., Leider, J.E., and Silverstein, S.C., Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane, J. Exp. Med., 144, 788, 1976.
133.
Griffin, F.M., Jr., Griffin, J.A., and Silverstein, S.C., Studies on the mechanisms of phagocytosis. II. The interaction of macrophages with anti-immunoglobulin IgG coated bone marrow-derived lymphocytes, J. Exp. Med., 144, 788, 1976.
134.
Weissmann, G. and Dukor, P., Role of lysosomes in immune responses, Adv. Immunol., 12, 283, 1970.
135.
Becker, E.L. and Henson, P.M., In vitro studies of immunologically induced secretion of mediators from cells and related phenomenon, Adv. Immunol., 17, 93, 1973.
136.
Ignarro, L.J., Regulation of lysosomal enzyme secretion: role in inflammation, Agents Actions, 4, 241, 1974.
Cheson, B.D., Curnutte, J.T., and Babior, B.M., The oxidative killing mechanism of the neutrophil, Clin. Immunol., 3, 1, 1977.
140.
Root, R.K. and Metcalf, J.A., H2O2 release from human granulocytes during phagocytosis: relationship to superoxide anion formation and cellular catabolism of H2O2: studies with normal and cytochalasin B treated cells, J. Clin. Invest., 60, 1266, 1977.
141.
Babior, B.M. and Crowley, C.A., Chronic granulomatous disease and other disorders of oxidative killing by phagocytes, in Metabolic Basis of Inherited Disease, Stanbury, J. B., Wyngaarden, J. B., Frederickson, D. S. et al., Eds., McGraw-Hill, New York, 1983, 1956.
142.
Tauber, A.I., Borregaard, N., Simons, E. et al., Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies, Medicine, 62, 286, 1983.
143.
Spielberg, S.P., Boxer, L.A., Oliver, J.M. et al., Oxidative damage to neutrophils in glutathione synthetase deficiency, Br. J. Haematol., 42, 215, 1979.
144.
Matheson, N.R., Wong, P.S., and Travis, J., Isolation and properties of human neutrophil myeloperoxidase, Biochemistry, 20, 325, 1981.
145.
Thomas, E.L., Myeloperoxidase, hydrogen peroxide, chloride antimicrobial system: nitrogen-chlorine derivatives of bacterial components in bactericidal action against Escherichia coli, Infect. Immun., 23, 522, 1979.
146.
McGuire, W.W., Spragg, R.G., Cohen, A.M. et al., Studies on the pathogenesis of the adult respiratory distress syndrome, J. Clin. Invest., 69, 543, 1982.
147.
Karnovsky, M.L., Chronic granulomatous disease - pieces of a cellular and molecular puzzle, Fed. Proc., 32, 1527, 1973.
148.
Cline, M.J., Leukocyte metabolism, in Regulation of Hematopoiesis, Vol. 2, Gordon, A. S., Ed., Plenum Press, New York, 1970, 1045.
Sbarra, A.J., Paul, B.B., Jacobs, A.A., Strauss, R.R., and Mitchell, G.W., Jr., Biochemical aspects of phagocytic cells as related to bacteriocidal function, J. Reticuloendothelial Soc., 11, 492, 1972.
151.
Klebanoff, S.J., Relationship of metabolism to function in the polymorphonuclear leukocyte, in The Molecular Basis of Electron Transport, Schultz, J. and Cameron, B. F., Eds., Academic Press, New York, 1972, 275.
152.
Stjernholm, R.L., Burns, C.P., and Hohnadel, J.H., Carbohydrate metabolism by leukocytes, Enzyme, 13, 7, 1972.
153.
Goldstein, I.M., Kaplan, H.B., Edelson, H.S., and Weissman, G., Ceruloplasmin: a scavenger of superoxide anion radicals, J. Biol. Chem., 254, 4040, 1979.
154.
Boxer, L.A., Hedley-Whyte, E.T., and Stossel, T.P., Neutrophil action dysfunction and abnormal neutrophil behavior, N. Engl. J. Med., 291, 1092, 1974.
155.
Clark, R.A. and Kimball, H.R., Defective granulocyte chemotaxis in the Chediak-Higashi syndrome, J. Clin. Invest., 50, 2645, 1971.
156.
Gailin, J.J., Abnormal chemotaxis: cellular and humoral components, in The Phagocytic Cell in Host Resistance, Bellanti, J. A. and Dayton, D. H., Eds., Raven Press, New York, 1975, 227.
157.
Mowat, A.G. and Baum, J., Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus, N. Engl. J. Med., 284, 621, 1971a.
158.
Miller, M.E. and Baker, L., Leukocytes function and juvenile diabetes mellitus: humoral and cellular aspects, J. Pediatr., 81, 979, 1974.
159.
Hill, H.R., Sauls, H.S., Dettloff, J.L., and Quie, P.G., Impaired leukotactic responsiveness in patients with juvenile diabetes mellitus, Clin. Immunol. Immunopathol., 2, 395, 1974b.
160.
Khan, A.J., Evans, H.E., Glass, L., Shin, Y.H., and Almonte, D., Defective neutrophil chemotaxis in patients with Down's syndrome, Pediatrics, 98, 87, 1975.
161.
Hill, H.R. and Quie, P.G., Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections, Lancet, 1, 183, 1974.
162.
Hill, H.R. and Quie, P.G., Defective neutrophil chemotaxis associated with hyperimmunoglobulinemia E, in The Phagocytic Cell in Host Resistance, Bellanti, J. A. and Dayton, D. H., Eds., Raven Press, New York, 1975, 249.
163.
Hill, H.R., Williams, P.B., Krueger, G.G., and Janis, B., Recurrent staphylococcal abscesses associated with defective neutrophil chemotaxis and allergic rhinitis, Ann. Intern. Med., 85, 39, 1976.
164.
Hill, H.R., Estensen, R.D., Hogan, N.A., and Quie, P.G., Severe staphylococcal disease associated with allergic manifestations, hyperimmunoglobulinemia E and defective neutrophil chemotaxis, J. Lab. Clin. Med., 88, 796, 1976b.
165.
Miller, M.E., Norman, M.E., Koplenzer, T.J., and Schoenauer, T., A new familiar defect on neutrophil movement, J. Lab. Clin. Med., 82, 1, 1973.
166.
Binder, V. and Riis, P., Leukocyte chemotactic function in patients with ulcerative colitis, Scand. J. Gastroenterol., 12, 141, 1977.
167.
Verspaget, H.W., Mieremet-Ooms, M.A.C., Weterman, I.T., and Pena, A.S., Partial defect of neutrophil oxidative metabolism in Crohn's disease, Gut, 25, 849, 1984.
168.
Hill, H.R., Ochs, H.D., Quie, P.G., Clark, R.A., Pabst, H.F., Klebanoff, S.J., and Wedgwood, R.J., Defect in neutrophil granulocyte chemotaxis in Job's syndrome of recurrent cold staphylococcal abscesses, Lancet, 2, 617, 1974.
Hill, H.R., Book, L.S., Hemming, V.G., and Herbst, J.J., Defective neutrophil chemotactic responses in patients with recurrent episodes of otitis media and chronic diarrhea, Am. J. Dis. Child., 131, 433, 1977.
174.
Zivkovic, M. and Baum, J., Chemotaxis of polymorphonuclear leukocytes from patients with systemic lupus erythematosis and Felty's syndrome, Immunol. Commun., 1, 39, 1972.
175.
Mowat, A.G. and Baum, J., Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis, J. Clin. Invest., 50, 2541, 1971b.
176.
Park, B.H., Dolen, J., and Snyder, B., Defective chemotactic migration of polymorphonuclear leukocytes in Pleger-Huet anomaly, Proc. Soc. Exp. Biol. Med., 155(1), 51, 1977.
177.
Walters, M.I., Lessler, M.A., and Stevenson, T.D., Oxidative metabolism of leukocytes from nondiabetic and diabetic patients, J. Lab. Clin. Med., 78, 158, 1971.
178.
Bagdade, J.D., Nielson, K.L., and Bulger, R.J., Reversible abnormalities and phagocytic function in poorly controlled diabetic patients, Am. J. Med. Sci., 263, 451, 1972.
179.
Bagdade, J.D., Root, R.K., and Bulger, R.J., Impaired leukocyte function in patients with poorly controlled diabetes, Diabetes, 23, 9, 1974.
180.
Okuda, K., Okamoto, R., Noguchi, Y., and Tadokoro, I., An investigation of leukocyte function and phagocytosis of immune complexes in patients with rheumatoid arthritis, Jpn. J. Exp. Med., 45, 1, 1975.
181.
Brandt, L. and Hedberg, H., Impaired phagocytosis by peripheral blood granulocytes in systemic lupus erythematosis, Scand. J. Haematol., 6, 348, 1969.
182.
Holmes, B., Quie, P.G., Windhorst, D.B., and Good, R.A., Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function, Lancet, 1, 1225, 1966.
183.
Lehrer, R.I. and Cline, M.J., Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection, J. Clin. Invest., 48, 1478, 1969.
184.
Lehrer, R.I., Hanifin, J., and Cline, M.J., Defective bacteriocidal activity in myeloperoxidase-deficient human neutrophils, Nature (London), 223, 78, 1969.
185.
Bauer, W.H., The supporting tissues of the tooth in acute secondary agranulocytosis (arsphenamin neutropenia), J. Dent. Res., 25, 501, 1946.
186.
Cohen, D.W. and Morris, A.L., Periodontal manifestation of cyclic neutropenia, J. Periodontol., 32, 159, 1961.
187.
Tempel, T.T., Kimball, H.R., Kakehasi, S., and Amen, C.R., Host factors in periodontal manifestation of Chediak-Higashi syndrome, J. Periodontal Res., 7(Suppl. 10), 26, 1972.
188.
Arnold, R.N. and Hoffman, D.L., Oral management of lazy leukocyte syndrome. A case report, Quintessence Int., 10, 9, 1979.
Issekutz, A.C., Lee, K.Y., and Biggar, W.D., Combined abnormality of neutrophil chemotaxis and bacteriocidal activity in a child with chronic skin infections, Clin. Immunol. Immunopathol., 14, 1, 1979.
191.
Clark, R.A., Root, R.K., Kimball, H.R., and Kirkpatrick, C.H., Defective neutrophil chemotaxis and cellular immunity in a child with recurrent infection, Ann. Intern. Med., 78, 515, 1973.
192.
Van Dyke, T.E., Taubman, M.A., Ebersole, J.L., Haffajee, A.D., Socransky, S.S., Smith, D.J., and Genco, R.J., The Papillon-LeFevre syndrome: neutrophil dysfunction with severe periodontal disease, Clin. Immunol. Immunopathol., 31P, 419, 1984.
193.
Van Dyke, T.E., Horoszewicz, H.U., and Genco, R.J., The polymorphonuclear leukocyte (PMNL) locomotor defect in juvenile periodontitis. Study of random migration, chemokinesis and chemotaxis, J. Periodontol., 53, 682, 1982b.
194.
Springer, T.A., Thompson, W.S., and Miller, L.J., Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis, J. Exp. Med., 160, 1901, 1984.
195.
Anderson, D.C., Schmalstieg, F.C., Arnout, M.A. et al., Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GD138): common relationship to diminished cell adherence, J. Clin. Invest., 74, 536, 1984.
196.
Anderson, D.C., Schmalstieg, F.C., Feingold, M.J. et al., The severe and moderate phenotypes of heritable Mac-1, LFA-1, pl50,95 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features, J. Infect. Dis., 152, 668, 1985.
197.
Waldrop, T.C., Anderson, D.C. et al., Periodontal manifestations of the heritable Mac-1, LFA-1, deficiency syndrome. Clinical, histopathologic and molecular characteristics, J. Periodontol., 58, 400, 1987.
198.
Page, R.C., Beatty, P., and Waldrop, T.C., Molecular basis for the functional abnormality in neutrophils from patients with generalized prepubertal periodontitis, J. Periodontal Res., 22, 182, 1987.
199.
Sanchez-Madrid, F., Krensky, A.M., Ware, C.F. et al., Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3, Proc. Natl. Acad. Sci. U.S.A., 79, 7489, 1982.
200.
Kurzinger, K., Ho, M.K., and Springer, T.A., Structure homology of a macrophage differentation antigen and an antigen involved in T-cell-mediated killing, Nature (London), 296, 668, 1982.
201.
Sanchez-Madrid, F., Simon, P., Thompson, S., and Springer, T.A., Mapping of antigenic and functional epitopes on the alpha and beta subunits of two related glycoproteins involved in cell interactions, LFA-1 and Mac-1, J. Exp. Med., 158, 586, 1983.
202.
Springer, T.A., Teplow, D.B., and Dreyer, W.J., Sequence homology of the LFA-1 and Mac-1 leukocyte adhesion glycoproteins and unexpected relation to leukocyte interferon, Nature (London), 314, 540, 1985.
203.
Crowley, C.A., Curnutte, J.T., Roson, R.E. et al., An inherited abnormality of neutrophil adhesion: its genetic transmission and its association with a missing protein, N. Engl. J. Med., 302, 1163, 1980.
204.
Hayward, A.R., Leonard, J., Wood, C.B.S. et al., Delayed separation of the umbilical cord, widespread infections, and defective neutrophil mobility, Lancet, 1, 1099, 1979.
205.
Arnaout, M.A., Pitt, J., Cohen, H.J. et al., Deficiency of a granulocyte-membrane glycoprotein (gpl50) in a boy with recurrent bacterial infections, N. Engl. J. Med., 306, 693, 1982.
206.
Bowen, T.J., Ochs, H.D., Altman, L.C. et al., Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein, J. Pediatr., 101, 932, 1982.
207.
Anderson, D.C., Schmalsteig, F.C., Aranout, M.A. et al., Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence, J. Clin. Invest., 74, 536, 1984.
208.
Springer, T.A., Thompson, W.S., Miller, L.J. et al., Inherited deficiency of the -1, Mac-1, pl50,95 glycoprotein family and its molecular basis, J. Exp. Med., 160, 1901, 1984.
209.
Aranout, M.A., Spits, H., Terhorst, C. et al., Deficiency of a leukocyte surface glycoprotein (LFA-1) on two patients with Mo-1 deficiency, J. Clin. Invest., 74, 1291, 1984.
210.
Beatty, P.G., Harlan, J.M., and Rosen, H., Absence of monoclonal-antibody defined protein complex in a boy with abnormal leukocyte function, Lancet, 1, 535, 1984.
211.
Ho, M.K. and Springer, T.A., Biosynthesis and assembly of the a and β subunits of Mac-1, a macrophage glycoprotein associated with complement receptor function, J. Biol. Chem., 258, 2766, 1983.
212.
Marlon, S.D., Morton, C.C., Anderson, D.C. et al., LFA-1 immunodeficiency disease: definition of the genetic defect and chromosomal mapping of alpha and beta subunits of the lymphocyte function-associated antigen 1 (LFA-1) by complementation in hybrid cells, J. Exp. Med., 164, 855, 1986.
213.
Corbi, A.L., Larson, R.S., Kishimoto, T.K. et al., Chromosomal location of the genes encoding the leukocyte adhesion receptors LFA-1, Mac-1 and p150,95: identification of a gene cluster involved in cell adhesion, J. Exp. Med., 167, 1597, 1988.
214.
Fischer, A., Descamps-Latsche, B., Gerota, I. et al., Bone marrow transplantation for inborn error of phagocytic cells associated with defective adherence, chemotaxis, and oxidative response during opsonised particle phagocytosis, Lancet, 2, 473, 1983.
215.
Bainton, D.F., Miller, L.J., Kishimoto, T.K., and Springer, T.A., Leukocyte adhesion receptors are stored in peroxidase-negative granules of human neutrophils, J. Exp. Med., 166, 1641, 1987.
216.
Ross, G.D., Thompson, R.A., Walport, M.J. et al., Characterization of patients with an increased susceptibility to bacterial infections and a genetic deficiency of leukocyte membrane complement receptor type 3 and the related membrane antigen LFA-1, Blood, 66, 882, 1985.
217.
Weening, R.S., Roos, D., Weemaes, C.M.C. et al., Defective initiation of the metabolic stimulation in phagocytizing granulocytes: a new congenital defect, J. Lam. Clin. Med., 88, 757, 1976.
218.
Page, R.C., Beatty, P., and Waldrop, T.C., Molecular basis for the functional abnormality in neutrophils from patients with generalized prepubertal periodontitis, J. Periodontol. Res., 22, 182, 1987.
219.
Waldrop, T.C., Anderson, D.C., Hallmon, W.W. et al., Periodontal manifestations of the heritable Mac-1, LFA-1 deficiency syndrome, J. Periodontol., 58, 400, 1987.
220.
Page, R.C. and Schroeder, H.E., Pathogenesis of inflammatory periodontal disease. A summary of current works, J. Lab. Invest., 33, 235, 1976.
221.
Simchowitz, L., Fischbein, L.C., Spilberg, I., and Atkinson, J.P., Induction of transient elevation in intracellular levels of adenosine-3',5'-cyclicmonophosphates by chemotactic factors: an early event in human neutrophils activation, J. Immunol., 124, 1482, 1980.
222.
Van Dyke, T.E., Horoszewicz, H.U., Cianciola, L.J., and Genco, R.J., Reduced chemotactic peptide binding in juvenile periodontitis: a model for neutrophil function, Biochem. Biophys. Res. Commun., 10, 1278, 1981.
223.
McKenna, J. and Van Oss, C.J., Defective polymorphonuclear leukocyte function in a human periodontal disease, Nature (London), 265, 445, 1977.
224.
Clark, R.A., Page, R.C., and Wilde, G., Defective neutrophil chemotaxis in juvenile periodontitis, Infect. Immun., 18, 694, 1977.
225.
Lavine, W.S., Maderazo, E.G., Stolman, J., Ward, P.A., Cogen, R.B., Greenblatt, I., and Robertson, P.B., Impaired neutrophil chemotaxis in patients with juvenile, rapidly progressing periodontitis, J. Periodontal Res., 14, 10, 1979.
226.
Vandesteen, G.E., Altman, L.C., and Page, R.C., Peripheral blood leukocyte abnormalities and periodontal disease, J. Periodontol., 52, 174, 1981.
227.
Page, R.C., Altman, L.C., Ebersole, J.L., Vandesteen, G.E., Dahlberg, W.H., Williams, B.L., and Osterberg, S.K., Rapidly pregressive periodontitis: a distinct clinical condition, J. Periodontol., 54, 197, 1983.
228.
Page, R.C., Bowen, T., Altman, L., Vandesteen, E., Ochs, H., Mackenzie, P., Osteberg, S., Engel, L.D., and Williams, B.L., Prepubertal periodontitis. I. Definition of a clinical disease entity, J. Periodontol., 54, 257, 1983.
229.
Bissada, N.F., Manouchehr-Pour, M., Haddow, M., and Spagnuolo, P.J., Neutrophil functional activity in juvenile and adult onset diabetic patients with mild and severe periodontitis, J. Periodontal Res., 17, 500, 1982.
230.
Cianciola, L.J., Park, B.H., Bruck, E., Mosovich, L., and Genco, R.J., Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes), JADA, 104, 653, 1982.
231.
Van Dyke, T.E., Horoszwicz, H.U., Cianciola, L.J., and Genco, R.J., Neutrophil chemotaxis dysfunction in human periodontitis, Infect. Immun., 27, 124, 1980.
232.
Tsai, C.-C., McArthur, W.P., Baehni, P.C., Hammond, B.F., and Taichman, N.S., Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism, Infect. Immun., 25, 427, 1979.
233.
Zambon, J.J., Deluca, C., Slots, J., and Genco, R.J., Studies of leukotoxin from Actinobacillus actinomycetemcomitans using the promyclocytic HL-60 cell line, Infect. Immun., 40, 205, 1983.
234.
Van Dyke, T.E., Bartholomew, E., Genco, R.J., Slots, J., and Levine, M.J., Inhibition of neutrophil chemotaxis by soluble bacterial products, J. Periodontol., 53, 502, 1982.
235.
Van Dyke, T.E., Levine, M.J., and Genco, R.J., Neutrophil function and oral disease, J. Oral Pathol., 14, 95, 1985.
236.
Genco, R.J., Van Dyke, T.E., Levine, M.J., Nelson, R.D., and Wilson, M.E., Molecular factors influencing neutrophil defects in periodontal disease, J. Dent. Res., 65, 1379, 1986.
237.
Ellegard, B. and Borregaard, J., Neutrophil chemotaxis and phagocytosis in juvenile periodontitis, J. Periodontal Res., 19, 261, 1984.
238.
Tew, J.G., Burneister, J.A., Palcanis, K.G., and Ranney, R.R., Spontaneous lymphocyte proliferation and periodontal status of young adults, J. Periodontal Res., 18, 534, 1983.
239.
Suzuki, J.B., Risom, L., Falker, W.A., Collison, C., and Gowers, G., Effect of periodontal therapy on lymphocyte response and neutrophil chemotaxis in localized and generalized juvenile periodontitis patients, J. Clin. Periodontol., 12, 124, 1985.
240.
Van Dyke, T.E., Levine, M.J., Tabak, L.A., and Genco, R.J., Periodontitis as a model for neutrophil function: reduced binding of the complement chemotactic fragment C5a, J. Dent. Res., 62, 870, 1983.
241.
Cotter, T.G. and Hensen, P.M., A cell surface differentiation antigen involved in human neutrophil chemotaxis and degranulation, Eur. J. Immunol., 14, 605, 1984.
242.
Kalmar, J.R., Arnold, R.R., and Van Dyke, T.E., Direct interaction of Actinobacillus actinomycetecomitans with normal and defective (LJP) neutrophils, J. Periodontol. Res., 22, 179, 1987.
243.
Suzuki, J.B., Burger, B., and Falker, W., Immunologic profile of juvenile periodontitis. II. Neutrophil chemotaxis, phagocytosis, and spore germination, J. Periodontol., 55, 461, 1984.
244.
Murray, P.A. and Patters, M.R., Gingival crevice neutrophil function in periodontal lesions, J. Periodontol. Res., 15, 463, 1980.
245.
Gillett, R. and Wilton, J.M.A., Transmission electron microscopy of inflammatory polymorphonuclear leukocytes from patients with juvenile periodontitis and normal subjects, J. Dent. Res., 60, 1975, 1981.
246.
Singh, S., Golub, L.M., Iacono, V.J., Nicoll, G., Ramamurthy, N.S., and Kaslick, R., In vivo crevicular leukocyte response in humans to chemotactic challenge: effects of periodontal disease, J. Periodontol., 55, 1, 1984.
247.
Ellegaard, B., Borregaard, N., and Ellegaard, J., Neutrophil chemotaxis and phagocytosis in juvenile periodontitis, J. Periodontol. Res., 19, 261, 1984.
248.
Daniel, M.A., McDonald, G., Offenbacher, S., and Van Dyke, T.E., Defective calcium mobilization in localized juvenile periodontitis neutrophils, J. Periodontol., submitted.
249.
Culp, K., Offenbacher, S., and Van Dyke, T.E., Reduced protein kinase C (PKC) activity in LJP neutrophils, J. Dent. Res., 68, 240, 1989.
250.
Tyagi, S., Lambeth, J.D., and Van Dyke, T.E., Altered signal transduction pathways in neutrophils from individuals with localized juvenile periodontitis, Science, submitted.
251.
Boxer, L.A. and Morganroth, M.L., Neutrophil function disorders, Disease-a-Month, December 1987.
252.
Dinauer, M., Parkos, C.A., and Jesaitis, A.J., Identification of the in vivo protein encoded by the gene mutated in X-linked chronic granulomatous disease, Clin. Res., 35, 598a, 1987.
253.
Curnutte, J.T. and Babior, B.M., Chronic granulomatous disease, in Advances in Human Genetics, Vol. 16, Harris, H. and Hirschhorn, K., Eds., Plenum Press, New York, 1987. 229.
254.
Martin, L.S., Spira, T.J., Orloff, S.L., and Holman, R.C., Comparison of methods for assessing chemotaxis of monocytes and polymorphonuclear leukocytes isolated from patients with AIDS or AIDS-related conditions, J. Leukocyte Biol., 44, 361, 1988.
255.
Ellis, M., Gupta, S., Galant, S., Hakim, S., VandeVen, C., Toy, C., and Cairo, M.S., Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation, J. Infect. Dis., 158, 1268, 1988.
256.
Murphy, P.M., Lane, H.C., Fauci, A.S., and Gallin, J.I., Impairment of neutrophil bactericidal capacity in patients with AIDS, J. Infect. Dis., 158, 627, 1988.
257.
Estevez, M.E., Ballart, I.J., Diez, R.A., Planes, N., Scaglione, C., and Sen, L., Early defect of phagocytic cell function in subjects at risk for acquired immunodeficiency syndrome, Scand. J. Immunol., 24, 215, 1986.
258.
Jouvin, M.H., Rozenbaum, W., Russo, R., and Kazatchkine, M.D., Decreased expression of the C3b/C4b complement receptor (Crl) in AIDS and AIDS-related syndromes correlates with clinical subpopulation of patients with HIV infection, AIDS, 1, 89, 1987.
259.
d'Onofrio, G., Mancini, S., Tamburrini, E., Mango, G., and Ortona, L., Giant neutrophils with increased peroxidase activity. Another evidence of dysgranuloopoiesis in AIDS, Am. J. Clin. Pathol., 87, 584, 1987.
260.
Murphy, M.F., Metcalfe, P., Waters, A.H., Carne, C.A., Weller, I.V., Linch, D.C., and Smith, A., Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection, Br. J. Haematol., 66, 337, 1987.
261.
Kazatchkine, M.D., Jouvin, M.H., Wilson, J.G., Fischer, E., and Fischer, A., Human diseases associated with C3 receptor deficiencies, Immunol. Lett., 14, 191, 1987.
262.
Nielsen, H., Kharazmi, A., and Faber, V., Blood monocyte and neutrophil functions in the acquired immune deficiency system, Scand. J. Immunol., 24, 291, 1986.
263.
Ras, G.J., Anderson, R., and Lukey, P.T., Defective polymorphonuclear leukocyte migration in AIDS, S. Afr. Med. J., 68, 292, 1985.
264.
Ras, G.J., Eftychis, H.A., Anderson, R., and van der Walt, I., Mononuclear and polymorphonuclear leucocyte dysfunction in male homosexuals with the acquired immunodeficiency syndrome (AIDS), S. Afr. Med. J., 66, 806, 1984.
265.
Spivak, J.L., Selonick, S.E., and Quinn, T.C., Acquired immune deficiency syndrome and pancytopenia, JAMA, 250, 3084, 1983.
266.
Greenspan, J.S., Greenspan, D., and Winkler, J.R., Diagnosis and management of the oral manifestations of HIV infection and AIDS, Infect. Dis. Clin. North Am., 2, 373, 1988.
267.
Winkler, J.R. and Murray, P.A., Periodontal disease. A potential intraoral expression of AIDS may be rapidly progressive periodontitis, CDA J., 15, 20, 1987.
268.
Murray, H.W., Hillman, J.K., Rubin, B.Y. et al., Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production, N. Engl. J. Med., 313, 1504, 1985.
269.
Ryder, M.I., Winkler, J.R., and Weinreb, R.N., Elevated phagocytosis, oxidative burst, and F-actin formation in PMNs from individuals with intraoral manifestation of HIV infection, J. Acquir. Immune Defic. Syndr., 1, 346, 1988.
270.
Kalmar, J.R., Host-Parasite Interaction in Human Periodontal Disease, Doctoral dissertation, 1989.